dc.contributor.author | Korkmaz, Taha Sukru | |
dc.contributor.author | Kemerdere, Rahsan | |
dc.contributor.author | Kayhan, Ahmet | |
dc.contributor.author | Tanriverdi, Taner | |
dc.contributor.author | Baran, Oguz | |
dc.date.accessioned | 2021-03-06T10:33:27Z | |
dc.date.available | 2021-03-06T10:33:27Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | Baran O., Kemerdere R., Korkmaz T. S. , Kayhan A., Tanriverdi T., "Can preoperative neutrophil to lymphocyte, lymphocyte to monocyte, or platelet to lymphocyte ratios differentiate glioblastoma from brain metastasis?", MEDICINE, cilt.98, 2019 | |
dc.identifier.issn | 0025-7974 | |
dc.identifier.other | av_eae63650-55c8-4160-8b45-4a77ffc85e77 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/154291 | |
dc.identifier.uri | https://doi.org/10.1097/md.0000000000018306 | |
dc.description.abstract | This retrospective analysis of patients aims to show the blood levels of preoperative inflammatory markers in patients with glioblastoma and brain metastasis and to provide the diagnostic accuracy of the neutrophil-lymphocyte (NLR), lymphocyte-monocyte (LMR), and platelet-lymphocyte (PLR) ratios between the 2 groups of patients. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.title | Can preoperative neutrophil to lymphocyte, lymphocyte to monocyte, or platelet to lymphocyte ratios differentiate glioblastoma from brain metastasis? | |
dc.type | Makale | |
dc.relation.journal | MEDICINE | |
dc.contributor.department | Istanbul Haseki Training & Research Hospital , , | |
dc.identifier.volume | 98 | |
dc.identifier.issue | 50 | |
dc.contributor.firstauthorID | 271208 | |